VANGUARD GROUP INC 13D and 13G filings for West Pharmaceutical Services, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 9,002,632 12.170% | 14,223 (+0.16%) | Filing |
| 2023-02-09 11:37 am Purchase | 2022-12-30 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 8,988,409 12.140% | 354,556 (+4.11%) | Filing |
| 2022-02-10 08:47 am Purchase | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 8,633,853 11.650% | 344,483 (+4.16%) | Filing |
| 2021-02-10 12:00 pm Purchase | 2020-12-31 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 8,289,370 11.210% | 790,257 (+10.54%) | Filing |
| 2020-02-11 7:29 pm Purchase | 2019-12-31 | 13G | West Pharmaceutical Services, Inc. WST | VANGUARD GROUP INC | 7,499,113 10.130% | 113,277 (+1.53%) | Filing |